Дэниел Амен - Мозг - от хорошего к превосходному

«Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids» (Washington, D.C.: National Academy Press, 2000).

Engelhart, M. J., et al. «Dietary Intake of Antioxidants and Risk of Alzheimer Disease», Journal of the American Medical Association 287, no. 24 (June 26, 2002): 3223–29.

Gray, S. L., et al. «Is Antioxidant Use Protective of Cognitive Function in the Community-Dwelling Elderly?» American Journal of Geriatric Pharmacotherapy I, no. 1 (September 2003): 3–10.

Lykkesfeldt, J., et al. «Ascorbate Is Depleted by Smoking and Repleted By Moderate Supplementation: A Study in Male Smokers and Nonsmokers with Matched Dietary Intakes», American Journal of Clinical Nutrition 71 (2000): 530–36.

Voko, Z., et al. «Dietary Antioxidants and the Risk of Ischemic Stroke: The Rotterdam Study», Neurology 61, no. 9 (November 11, 2003): 1273–75.

Adler, L. A., et al. «Vitamin E Treatment for Tardive Dyskinesia», Archives of General Psychiatry 56 (1999): 836–41.

Anderson, D. К., T. R. Waters, and E. D. Means, «Pretreatment with Alpha-Tocopherol Enhances Neurologic Recovery After Experimental Spinal Cord Compression Injury», Journal of Neurotrauma 5, no. 61 (1998): 61–67.

Aslam, A., et al. «Vitamin E Deficiency Induced Neurological Disease in Common Variable Immunodeficiency: Two Cases and a Review of the Literature of Vitamin E Deficiency», Clinical Immunology 112, no. 1 (July 2004): 24–29.

Engelhart, M. J., et al. «Dietary Intake of Antioxidants and Risk of Alzheimer Disease», Journal of the American Medical Association 287, no. 24 (June 26, 2002): 3223–29.

GISSI-Prevenzionc Investigators, «Dietary Supplementation with N-3 Polyunsaturated Fatty Acids and Vitamin E after Myocardial Infarction: Results of the GlSSI-Prevenzioni Trial», Lancet 354 (1999): 447–55.

Gray, S. I., et al. «Predictors of Nutritional Supplement Use by the Elderly», Pharmacotherapy 16, no. 4 (July-August 1996): 715–20.

Gray, S. L., et al. «Is Antioxidant Use Protective of Cognitive Function in the Community-Dwelling Elderly?» American Journal of Geriatric Pharmacotherapy 1, no. 1 (September 2003): 3–10.

Grundman, M., «Vitamin E and Alzheimer’s Disease: The Basis for Additional Clinical Trials», American Journal of Clinical Nutrition 71 (2000): 630S-36S.

Miller, E. R., Ill, et al. «Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality», Annals of Internal Medicine (January 4, 2005): 37–46.

Rimm, E. B., et al. «Vitamin E Consumption and the Risk of Coronary Heart Disease in Men», New England Journal of Medicine 328, no. 20 (May 20, 1993): 1450–56.

Rutten, B. P., et al. «Antioxidants and Alzheimer’s Disease: From Bench to Bedside (and Back Again)», Current Opinion in Clinical Nutrition and Metabolic Care 5, no. 6 (November 2002): 645–51.

Shoulson, I., «DATATOP: A Decade of Neuroprotective Inquiry. Parkinson Study Group. Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism», Annals of Neurology 44, no. 3 suppl. 1 (1998): S160–66.

Stampfer, M. J., et al. «Vitamin E Consumption and the Risk of Coronary Disease in Women», New England Journal of Medicine 328, no. 20 (May 20, 1993): 1444–49.

Iraber, M. G., «Which Form of Vitamin E, Alpha-or Gamma-Tocopherol, Is Better?» Linus Pauling Institute Report (2002).

Voko, Z., et al. «Dietary Antioxidants and the Risk of Ischemic Stroke: The Rotterdam Study», Neurology 61, no. 9 (November 11, 2003): 1273–75.

Wu, A., Z. Ying, and F. Gomez-Pinilla, «The Interplay Between Oxidative Stress and Brain-Derived Neurotrophic Factor Modulates the Outcome of a Saturated Fat Diet on Synaptic Plasticity and Cognition», European Journal of Neuroscience 19, no. 7 (April 2004): 1699–707.

Bell, К. М., et al. «S-Adenosylmethionine Treatment of Depression: A Controlled Clinical Trial», American Journal of Psychiatry 145, no. 9 (1988): 1110–14.

Bell, К. М., et al. «S-Adenosylmethionine Blood Levels in Major Depression: Changes with Drug Treatment», Acta Neurologica Scandinavica 154 (Suppl.) (1994): 15–18.

Berlanga, C., et al. «Efficacy of S-Adenosyl-L-Methionine in Speeding the Onset of Action of Imipramine», Psychiatry Research 44, no. 3 (1992): 257–62.

Glorioso, S., et al. «Double-Blind Multicentre Study of the Activity of S-Adenosylmethionine in Hip and Knee Osteoarthritis», International Journal of Clinical Pharmacology Research 5, no. 1 (1985): 39–49.

Jacobsen, S., B. Danneskiold-Samsoe, and R. B. Andersen, «Oral S-Adenosylmethionine in Primary Fibromyalgia. Double-Blind Clinical Evaluation», Scandinavian Journal of Rheumatology 20, no. 4 (1991): 294–302.

Kagan, B. L., et al. «Oral S-Adenosylmethionine in Depression: A Randomized, Double-Blind, Placebo-Controlled Trial», American Journal of Psychiatry 147, no. 5 (1990): 591–95.

Maccagno, A., et al. «Double-Blind Controlled Clinical Trial of Oral S-Adenosylmethionine Versus Piroxicam in Knee Osteoarthritis», American Journal of Medicine 83, no. 5A (1987): 72–77.

Mantero, M., et al. «Controlled Double-Blind Study (SAMe-Imipramine) in Depressive Syndromes», Minerva Medica 66, no. 78 (1975): 4098–101.

Muller-Fassbender, H., «Double-Blind Clinical Trial of S-Adenosylmethionine Versus Ibuprofen in the Treatment of Osteoarthritis», American Journal of Medicine 83, no. 5A (1987): 81–83.

Salmaggi, P., et al. «Double-Blind, Placebo-Controlled Study of S-Adenosyl-L-Methionine in Depressed Postmenopausal Women», Psychotherapy and Psychosomatics 59, no. 1 (1993): 34–40.

Tavoni, A., et al. «Evaluation of S-Adenosylmethionine in Primary Fibromyalgia. A Double-Blind Crossover Study», American Journal of Medicine 83, no. 5A (1987): 107–10.

Vetter, G., «Double-Blind Comparative Clinical Trial with S-Adenosylmethionine and Indomethacin in the Treatment of Osteoarthritis», American Journal of Medicine 83, no. 5A (1987): 78–80.

Volkmann, H., et al. «Double-Blind, Placebo-Controlled Cross-over Study of Intravenous S-Adenosyl-L-Methionine in Patients with Fibromyalgia», Scandinavian Journal of Rheumatology 26, no. 3 (1997): 206–11.

Behnke, K., et al. «Hypericum Perforatum Versus Fluoxetine in the Treatment of Mild to Moderate Depression», Advances in therapy 19, no. 1 (2002): 43–52.

Brenner, R., et al. «Comparison of an Extract of Hypericum (LI 160) and Sertraline in the Treatment of Depression: A Double-blind, Randomized Pilot Study», Clinical Therapeutics 22, no. 4 (2000): 411–19.

Czekalla, J., et al. «The Effect of Hypericum Extract on Cardiac Conduction as Seen in the Electrocardiogram Compared to that of Imipramine», Pharmacopsychiatry 30, suppl. 2 (1990): 86–88.

Friede, М., H. H. Henneicke von Zepelin, and J. Freudenstein, «Differential Therapy of Mild to Moderate Depressive Episodes (ICD-10 F 32.0; F 32.1) with St. John’s Wort», Pharmacopsychiatry 34, Suppl 1 (2001): S38–41.

Hansgen, K., D. J. Vesper, and M. Ploch, «Multicenter Double-Blind Study Examining the Antidepressant Effectiveness of the Hypericum Extract LI 160», Journal of Geriatric Psychiatry and Neurology 7, Suppl. 1 (1994): S15–18.

Harrer, G., W. D. Hubner, and H. Podzuweit, «Effectiveness and Tolerance of the Hypericum Extract LI 16 °Compared to Maprotiline: A Multicenter Double-Blind Study», Journal of Geriatric Psychiatry and Neurology 7, Suppl. 1 (1994): S24–28.